Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMC

THE NLRC4 INFLAMMASOME CONTRIBUTES TO BRAIN INFLAMMAGING

de Rivero Vaccari J., Mejias N., Travascio F.

Laboratory Study on Stroke Research, Spinal Cord Injury, Neuroinflammation, Chronic Inflammation, published in Innov Aging (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Innov Aging (2017)
Reported sample size
—
Source database
Europe PMC
PMCID
PMC6185606

Abstract (original English)

Abstract Inflammation is a natural part of aging in a process known as inflammaging. Inflammaging has been associated with deleterious outcomes in the aging brain. It is believed that inflammaging precedes the onset of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The inflammasome is an arm of the innate immune response involved in the activation of the inflammatory caspase-1 and the processing of the pro-inflammatory cytokines interleukin (IL)-1b and IL-18. We have previously shown that inflammasome contributes to the inflammatory response in the central nervous system after brain and spinal cord injury as well as stroke. In addition, we have shown that inflammasome inhibition in the aging brain results in improved cognitive outcomes. In this study we analyzed the brain of young (3 months old) and aged (18 months old) mice for the expression of inflammasome proteins. Our findings indicate that the inflammasome proteins NLRC4, caspase-1, ASC, and IL-18 are elevated in the cytoplasm of cortical lysates in aged mice when compared to young. Similarly, in the cytoplasmic fraction of hippocampal lysates in aged mice, we found an increase in NLRC4, caspase-1, caspase-11, ASC and IL-1b. Moreover, ASC is involved in the cell death mechanism of pyroptosis. Interestingly, the pyroptosome is elevated in the brain of aged mice. Taken together, our data ind

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research